arrow
O

Olivier Gléhen

centre hospitalier lyon sud
H指数:77
被引数:2.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Structured operative reporting for cytoreductive surgery: the CRS-Report platform

细胞减灭术的结构化操作报告:CRS-Report平台

EJSO
IF2.9
2026-10-130
PRE
Prophylactic ureteral stenting during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Impact on symptomatic ureteral events requiring renal drainage

在细胞减灭术和温热腹腔化疗期间进行预防性输尿管支架置入:对需要肾脏引流的有症状输尿管事件的影响

EJSO
IF2.9
2026-10-120
OA
First-Line Fluoropyrimidine- versus Gemcitabine-Based Chemotherapy for Metastatic Recurrence After Resection of Ampullary Adenocarcinoma: a Real-World Analysis of the FFCD-AC Cohort

壶腹腺癌切除术后转移性复发的氟嘧啶类与吉西他滨为基础的化疗比较:FFCD-AC队列的真实世界分析

2026-10-090
OAAI
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for pancreatic cancer peritoneal metastases: A retrospective multicentric study from the ISSPP PIPAC Database

经加压腹腔气溶胶化疗治疗胰腺癌腹膜转移:一项来自ISSPP PIPAC数据库的多中心回顾性研究

EJSO
IF2.9
2026-08-010
PRE
Feasibility and safety profile of high-dose oxaliplatin-based PIPAC (120mg/m2) in the treatment of advanced peritoneal metastatic disease: MINOS real-life multicenter study

高剂量奥沙利铂为基础的PIPAC(120mg/m²)治疗晚期腹膜转移性疾病的可行性与安全性特征:MINOS真实世界多中心研究

2026-03-040
OAAI
ASO Visual Abstract: Appendiceal Adenocarcinoma Discovered during Acute Perforated Appendicitis: A Potential Contribution of Prophylactic CRS and HIPEC, a French BIGRENAPE Group Study

ASO视觉摘要:急性穿孔性阑尾炎期间发现的阑尾腺癌:预防性CRS和HIPEC的潜在贡献,法国BIGRENAPE研究小组研究

2026-01-070
PRE
Exome sequencing points to pathogenic ATM variants in gastric cancer

外显子测序指向胃癌中的致病性ATM变异。

2025-12-260
OAAI
Correction: Appendiceal Adenocarcinoma Discovered During Acute Perforated Appendicitis: A Potential Contribution of Prophylactic CRS and HIPEC—A French BIGRENAPE Group Study

更正:急性穿孔性阑尾炎期间发现的阑尾腺癌:预防性CRS和HIPEC的潜在贡献——法国BIGRENAPE小组研究

2025-12-140
OAAI
Proposed strategy after complete LAMN (low-grade appendiceal mucinous neoplasm) resection by different RENAPE units: need for a new consensus?

不同RENAPE单位在完全切除低级别阑尾黏液性肿瘤(LAMN)后的建议策略:是否需要新的共识?

2025-12-010
OAAI
Appendiceal Adenocarcinoma Discovered During Acute Perforated Appendicitis: A Potential Contribution of Prophylactic CRS and HIPEC—A French BIGRENAPE Group Study

阑尾腺癌在急性穿孔性阑尾炎中发现:预防性CRS和HIPEC的潜在贡献——法国BIGRENAPE研究组研究

2025-11-250
PRE
Multiparametric assessment of tumor pathological regression grade of peritoneal metastases from non-mucinous colorectal cancer during neoadjuvant chemotherapy using dual-energy CT

使用双能量CT对非黏液性结直肠癌腹膜转移灶在化疗新辅助治疗期间进行多参数评估肿瘤病理退缩分级

2025-10-310
PRE
ASO Author Reflections: Preoperative Peritoneal MRI Used as the Peritoneal Surgeon’s Headlamp Helping to Achieve a Complete Cytoreductive Surgery in Patients with Abdominal Surgical History

ASO作者反思:作为腹腔外科医生“探照灯”的术前腹膜MRI,有助于在具有腹部手术史的患者中实现完全细胞减灭术。

2025-10-060
PRE
Assessing the Annual Risk of Recurrence Following Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Diffuse Malignant Peritoneal Mesothelioma Patients

评估弥漫性恶性腹膜间皮瘤患者行完全细胞减灭术联合温热腹腔化疗(HIPEC)后的年度复发风险

2025-09-260
PRE
ASO Visual Abstract: Preoperative Peritoneal MRI: Usefulness to Highlight Potential Hidden Lesions for Complete Cytoreductive Surgery in Colorectal Cancer Patients with Surgical History

ASO视觉摘要:术前腹膜MRI:在具有手术史的大肠癌患者中,完全细胞减灭术用于突出潜在隐匿病灶的实用性

2025-09-090
PRE